Two Topical K40 Formulations in Adults With Seborrhoeic Dermatitis (SD) of the Scalp

Clinical trial NCT01137630 · COMPLETED

Trial details

NCT number: NCT01137630
Sponsor: Moberg Pharma AB
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Seborrhoeic Dermatitis of the Scalp

Start date: 2007-02-01
Primary completion: 2007-05-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.